
Pool Corporation to Present at the Oppenheimer 20th Annual Industrial Growth Conference
COVINGTON, La., April 28, 2025 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq:POOL) announced today that Melanie M. Hart, Senior Vice President and Chief Financial Officer, will participate in the Oppen...
- April 28, 2025 01:05 PM PDT
- EODHD

Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting
BRISBANE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeut...
- April 28, 2025 01:05 PM PDT
- EODHD

LifeMD to Report First Quarter 2025 Financial Results on May 6
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ende...
- April 28, 2025 01:05 PM PDT
- EODHD

Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025
SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug...
- April 28, 2025 01:05 PM PDT
- EODHD

CORCEPT THERAPEUTICS TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS, PROVIDE CORPORATE UPDATE AND HOST CONFERENCE CALL
REDWOOD CITY, Calif., April 28, 2025--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter financial results and provide a corporate update on...
- April 28, 2025 01:05 PM PDT
- EODHD

Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call
ROMEOVILLE, Ill., April 28, 2025 (GLOBE NEWSWIRE) -- Romeoville, Ill., April 28, 2025 – Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life s...
- April 28, 2025 01:01 PM PDT
- EODHD

Bicara Therapeutics Highlights Broad Potential of Ficerafusp Alfa at AACR Annual Meeting 2025
BOSTON, April 28, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients w...
- April 28, 2025 01:01 PM PDT
- EODHD

AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS
THOUSAND OAKS, Calif., April 28, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2025 financial results on Thursday, May 1, 2025, after the close of the...
- April 28, 2025 01:01 PM PDT
- EODHD

Honoring Monroe’s Birthday: New Study Highlights His Drafting Of America’s First Organic Territorial Law
COLONIAL BEACH, Va., April 28, 2025 (SEND2PRESS NEWSWIRE) -- The James Monroe Memorial Foundation proudly announces the publication of "United States in Congress Assembled Delegate James Monroe: Archi...
- April 28, 2025 01:00 PM PDT
- Send2Press

Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs
Nurix’s DEL-AI platform uses a first-in-class DEL Foundation Model trained on the Company’s proprietary DNA encoded library data Nurix’s DEL Foundation Model can accurately predict novel binders to th...
- April 28, 2025 01:00 PM PDT
- EODHD